EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder

Nerea Requena-Ocaña, Pedro Araos iD, Pedro J Serrano-Castro iD, María Flores-López iD, Nuria García-Marchena iD, Begoña Oliver-Martos iD, Juan Jesús Ruiz, Ana Gavito, Francisco Javier Pavón iD, Antonia Serrano, Fermín Mayoral iD, Juan Suarez iD und 1 weitere

International Journal of Molecular Sciences · 07.01.2023 · 24 (2) · 1183

DOI: 10.3390/ijms24021183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.01.2023. Verfasst von Nerea Requena-Ocaña und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neuropsychopharmacology Group, Instituto IBIMA, Hospital Regional Universitario de Málaga, Avda. Carlos Haya 82, Sótano, 29010 Malaga, Spain. Hauptthemen laut MEDLINE: Alcoholism, Cognitive Dysfunction, Dementia, Alzheimer Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III - ERDF-EU, Instituto de Salud Carlos III, Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For a long time, Substance Use Disorders (SUDs) were not considered a component in the etiology of dementia. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders introduced substance-induced neurocognitive disorders, incorporating this notion to clinical practice. However, detection and monitoring of neurodegenerative processes in SUD patients remain a major clinical challenge, especially when early diagnosis is required. In the present study, we aimed to investigate new potential biomarkers of neurodegeneration that could predict cognitive impairment in SUD patients: the circulating concentrations of Neurofilament Light chain protein (NfL) and Brain-Derived Neurotrophic Factor (BDNF). Sixty SUD patients were compared with twenty-seven dementia patients and forty healthy controls. SUD patients were recruited and assessed using the Psychiatric Research Interview for Substance and Mental (PRISM) and a battery of neuropsychological tests, including the Montreal Cognitive Assessment test for evaluation of cognitive impairment. When compared to healthy control subjects, SUD patients showed increases in plasma NfL concentrations and NfL/BDNF ratio, as well as reduced plasma BDNF levels. These changes were remarkable in SUD patients with moderate–severe cognitive impairment, being comparable to those observed in dementia patients. NfL concentrations correlated with executive function and memory cognition in SUD patients. The parameters “age”, “NfL/BDNF ratio”, “first time alcohol use”, “age of onset of alcohol use disorder”, and “length of alcohol use disorder diagnosis” were able to stratify our SUD sample into patients with cognitive impairment from those without cognitive dysfunction with great specificity and sensibility. In conclusion, we propose the combined use of NfL and BDNF (NfL/BDNF ratio) to monitor substance-induced neurocognitive disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismCognitive DysfunctionDementiaAlzheimer DiseaseHumansBrain-Derived Neurotrophic FactorIntermediate FilamentsNeurofilament ProteinsBiomarkers

Stichwörter der Autor:innen

addictionalcohol use disorderbrain-derived neurotrophic factorcognitive impairmentdementianeurodegenerationneurofilament light chain protein

Substanzen

Brain-Derived Neurotrophic FactorNeurofilament ProteinsBiomarkers

Autor:innen und Institutionen

  • Neuropsychopharmacology Group, Instituto IBIMA, Hospital Regional Universitario de Málaga, Avda. Carlos Haya 82, Sótano, 29010 Malaga, Spain.
  • School of Psychology, Complutense University of Madrid, Campus de Somosaguas, 28040 Madrid, Spain.
  • Andalusian Network for Clinical and Translational Research in Neurology (NEURO-RECA), 29010 Malaga, Spain.
  • Neurology Service, Regional University Hospital of Malaga, 29010 Malaga, Spain.
  • Institute D, Research in Health Sciences Germans Trias i Pujol (IGTP), Addictions Unit-Internal Medicine Service, Campus Can Ruti, Carrer del Canyet s/n, 08916 Badalona, Spain.
  • Provincial Drug Addiction Center (CPD) of Malaga, Provincial Council of Malaga, C/Ana Solo de Zaldívar, n3, 29010 Malaga, Spain.

ORCID-Profile: Pedro Araos, Pedro J Serrano-Castro, María Flores-López, Nuria García-Marchena, Begoña Oliver-Martos, Francisco Javier Pavón, Fermín Mayoral, Juan Suarez, Fernando Rodríguez de Fonseca

Förderung

  • Instituto de Salud Carlos III - ERDF-EU
  • Instituto de Salud Carlos III
  • Ministry of Health
  • Instituto de Salud Carlos III (ISCIII]
  • Programa RICORS RIAPAD (Red de Investigación en Atención Primaria en Adicciones)
  • Ministerio de Sanidad, Delegación de Gobierno para el Plan Nacional sobre Drogas
  • Consejería de Salud y Familia, Junta de Andalucía
  • National System of Health, ISCIII, ERDF-EU

Zitieren

APA

Requena-Ocaña, N., Araos, P., Serrano-Castro, P. J., Flores-López, M., García-Marchena, N., Oliver-Martos, B., Ruiz, J. J., Gavito, A., Pavón, F. J., Serrano, A., Mayoral, F., Suarez, J., & Fonseca, F. R. (2023). Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder. International Journal of Molecular Sciences, 24(2), 1183. https://doi.org/10.3390/ijms24021183

Vancouver

Requena-Ocaña N, Araos P, Serrano-Castro PJ, Flores-López M, García-Marchena N, Oliver-Martos B, et al. Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder. International Journal of Molecular Sciences. 2023;24(2):1183. doi:10.3390/ijms24021183

BibTeX
@article{RequenaOcaa2023,
  author = {Requena-Ocaña, Nerea and Araos, Pedro and Serrano-Castro, Pedro J and Flores-López, María and García-Marchena, Nuria and Oliver-Martos, Begoña and Ruiz, Juan Jesús and Gavito, Ana and Pavón, Francisco Javier and Serrano, Antonia and Mayoral, Fermín and Suarez, Juan and Fonseca, Fernando Rodríguez de},
  title = {Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {1183},
  doi = {10.3390/ijms24021183}
}
Kostenlos starten →